dc.creatorMonteiro, Edna de Almeida
dc.creatorOsorio, Flavia de Lima
dc.creatorVeriano Junior, Alexandre
dc.creatorMolina, Roberto Souza
dc.creatorFunayama, Sandra Souza
dc.creatorTerra, Vera Cristina
dc.creatorVelasco, Tonicarlo R.
dc.creatorGuarnieri, Ricardo
dc.creatorBianchin, Marino
dc.creatorAssirati, Joao Alberto, Jr.
dc.creatorSakamoto, Americo Ceiki
dc.creatorCecilio Hallak, Jaime Eduardo
dc.date.accessioned2013-10-15T17:18:06Z
dc.date.accessioned2018-07-04T16:20:04Z
dc.date.available2013-10-15T17:18:06Z
dc.date.available2018-07-04T16:20:04Z
dc.date.created2013-10-15T17:18:06Z
dc.date.issued2012-07
dc.identifierEPILEPSY & BEHAVIOR, SAN DIEGO, v. 24, n. 3, pp. 345-351, JUL, 2012
dc.identifier1525-5050
dc.identifierhttp://www.producao.usp.br/handle/BDPI/35127
dc.identifier10.1016/j.yebeh.2012.04.129
dc.identifierhttp://dx.doi.org/10.1016/j.yebeh.2012.04.129
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1634510
dc.description.abstractThe objectives of the study were to translate and adapt the Subjective Handicap of Epilepsy (SHE) instrument to Brazilian Portuguese and to determine its psychometric properties for the evaluation of quality of life in patients with epilepsy. A sample of 448 adult patients with epilepsy with different clinical profiles (investigation, preoperative period, postoperative period, and drug treatment follow-up) was evaluated with the SHE and the Epilepsy Surgery Inventory (ESI-55). Exploratory factorial analysis demonstrated that four factors explained 60.47% of the variance and were sensitive to discriminate the different clinical groups, with the preoperative group having the poorest quality of life. Internal consistency ranged from 0.92 to 0.96, and concurrent validity with the ESI-55 was moderate/strong (0.32-0.70). Test-retest reliability was confirmed, with an ICC value of 0.54 (2 days), 0.91 (7 days), and 0.97 (30 days). The SHE had satisfactory psychometric qualities for use in the Brazilian population, similar to those of the original version. The instrument seems to be more adequate in psychometric terms for the postoperative and drug treatment follow-up groups, and its use should be encouraged. (c) 2012 Elsevier Inc. All rights reserved.
dc.languageeng
dc.publisherACADEMIC PRESS INC ELSEVIER SCIENCE
dc.publisherSAN DIEGO
dc.relationEPILEPSY & BEHAVIOR
dc.rightsCopyright ACADEMIC PRESS INC ELSEVIER SCIENCE
dc.rightsopenAccess
dc.subjectEPILEPSY
dc.subjectQUALITY OF LIFE
dc.subjectINSTRUMENT
dc.subjectVALIDATION
dc.subjectTRANSCULTURAL
dc.subjectSUBJECTIVE HANDICAP OF EPILEPSY
dc.titleValidation of the Subjective Handicap of Epilepsy (SHE) in Brazilian patients with epilepsy
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución